Circadian Rhythms in Postmenopausal Women
Julie Pendergast · with National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · NCT04893226
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 45–65 · Women only
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 164
- US sites recruiting
- 1
- Study start
- October 19, 2021
- Record last updated
- August 10, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This is a randomized, parallel two-arm clinical trial design to study the efficacy of time-restricted feeding on metabolic risk in postmenopausal women, who may be particularly vulnerable to disruption of circadian eating rhythms and the associated metabolic dysfunction. It is hypothesized that time-restricted feeding will improve insulin sensitivity, glucose tolerance, body weight, and other metabolic parameters in metabolically-unhealthy postmenopausal women.
Being studied: Time-Restricted Feeding (TRF)
Conditions: Metabolic Syndrome; Postmenopausal Symptoms
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- postmenopausal women
- age 45-65 years
- prediabetic or have at least 2 features of metabolic syndrome
Exclusion Criteria
- on hormone therapy
- diabetes
- heart disease
- alcohol consumption of >2 drinks per day
- significant circadian disruption
- having care-taking responsibilities that significantly affect sleep
- shift work or irregular lifestyle
- uncontrolled sleep apnea or other uncontrolled sleep disorder
- extreme early or late chronotypes
- significant psychiatric disorders
- taking ADHD medications
- diagnosed dysregulated eating behaviors
- smoking >5 cigarettes/day or 30 pack-year history
- participating in formal weight loss program
- not weight stable
Recruiting US locations
University of Kentucky
Lexington, KY 40536
Site contact: Matt Thomas, PhD · (859) 218-6770 · jmthomg@uky.edu
Study contacts (from the official record)
- Matt Thomas, PhD · (859) 218-6770 · jmthomg@uky.edu
Similar studies in Kentucky
All weight loss studies in Kentucky →- RecruitingPhase 2
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
AbbVie
- Location
- Louisville, KY + 58 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Study to Learn About Switching to a Monthly Study Medicine Called Berobenatide (PF-08653944) to Help Keep Weight Off in People With Overweight or Obesity
Pfizer
- Location
- Louisville, KY + 4 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
Hoffmann-La Roche
- Location
- Louisville, KY + 43 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
AstraZeneca
- Location
- Louisville, KY + 43 other US sites
- Eligibility basics
- Ages 18+